559 related articles for article (PubMed ID: 25284616)
1. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study.
Nery F; Chevret S; Condat B; de Raucourt E; Boudaoud L; Rautou PE; Plessier A; Roulot D; Chaffaut C; Bourcier V; Trinchet JC; Valla DC;
Hepatology; 2015 Feb; 61(2):660-7. PubMed ID: 25284616
[TBL] [Abstract][Full Text] [Related]
2. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
[TBL] [Abstract][Full Text] [Related]
3. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors.
Mangia A; Villani MR; Cappucci G; Santoro R; Ricciardi R; Facciorusso D; Leandro G; Caruso N; Andriulli A
Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):745-51. PubMed ID: 15947552
[TBL] [Abstract][Full Text] [Related]
4. [Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors].
Lin GS; Xu Q; Zhao SY; Zhang YX
Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):513-517. PubMed ID: 27784429
[No Abstract] [Full Text] [Related]
5. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.
Amitrano L; Guardascione MA; Brancaccio V; Margaglione M; Manguso F; Iannaccone L; Grandone E; Balzano A
J Hepatol; 2004 May; 40(5):736-41. PubMed ID: 15094219
[TBL] [Abstract][Full Text] [Related]
6. Portal vein thrombosis and survival in patients with cirrhosis.
Englesbe MJ; Kubus J; Muhammad W; Sonnenday CJ; Welling T; Punch JD; Lynch RJ; Marrero JA; Pelletier SJ
Liver Transpl; 2010 Jan; 16(1):83-90. PubMed ID: 20035521
[TBL] [Abstract][Full Text] [Related]
7. Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study.
Noronha Ferreira C; Marinho RT; Cortez-Pinto H; Ferreira P; Dias MS; Vasconcelos M; Alexandrino P; Serejo F; Pedro AJ; Gonçalves A; Palma S; Leite I; Reis D; Damião F; Valente A; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
Liver Int; 2019 Aug; 39(8):1459-1467. PubMed ID: 31021512
[TBL] [Abstract][Full Text] [Related]
8. Portal vein thrombosis associated with high 14-day and 6-week rebleeding in patients after oesophageal variceal band ligation: a retrospective, multicentre, nested case-control study.
Gao Z; Zhao J; Liu X; Li S; Wang M; Gao Y
Hepatol Int; 2021 Oct; 15(5):1183-1195. PubMed ID: 34292507
[TBL] [Abstract][Full Text] [Related]
9. The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients.
Zampino R; Lebano R; Coppola N; Macera M; Grandone A; Rinaldi L; De Sio I; Tufano A; Stornaiuolo G; Adinolfi LE; Durante-Mangoni E; Battista GG; Niglio A
Saudi J Gastroenterol; 2018; 24(1):25-29. PubMed ID: 29451181
[TBL] [Abstract][Full Text] [Related]
10. [Correlational study on portal vein thrombosis of liver cirrhosis].
Xu DQ; Yang JH
Zhonghua Gan Zang Bing Za Zhi; 2020 Jul; 28(7):573-579. PubMed ID: 32791792
[No Abstract] [Full Text] [Related]
11. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
[TBL] [Abstract][Full Text] [Related]
12. Systemic inflammation as a risk factor for portal vein thrombosis in cirrhosis: a prospective longitudinal study.
Nery F; Carneiro P; Correia S; Macedo C; Gandara J; Lopes V; Valadares D; Ferreira S; Oliveira J; Teixeira Gomes M; Miranda HP; Rautou PE; Valla D
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e108-e113. PubMed ID: 33208682
[TBL] [Abstract][Full Text] [Related]
13. [Preoperative risk factors of portal venous thrombosis after splenectomy and gastric pericardial devascularization for portal hypertension].
Han J; Yi Y; Ding H; Liu J; Zhang Y; Hu L; Zhao L; Liu T
Zhonghua Gan Zang Bing Za Zhi; 2014 Oct; 22(10):739-43. PubMed ID: 25496862
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis.
Artaza T; Lopes M; Romero M; Gómez AZ; de la Cruz G; Sánchez JJ; González C; Gómez R
Gastroenterol Hepatol; 2018 Dec; 41(10):611-617. PubMed ID: 30049580
[TBL] [Abstract][Full Text] [Related]
15. Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis.
Berry K; Taylor J; Liou IW; Ioannou GN
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):585-93. PubMed ID: 25459555
[TBL] [Abstract][Full Text] [Related]
16. Portal vein thrombosis: what is new?
Manzano-Robleda Mdel C; Barranco-Fragoso B; Uribe M; Méndez-Sánchez N
Ann Hepatol; 2015; 14(1):20-7. PubMed ID: 25536638
[TBL] [Abstract][Full Text] [Related]
17. Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
Pettinari I; Vukotic R; Stefanescu H; Pecorelli A; Morelli M; Grigoras C; Sparchez Z; Andreone P; Piscaglia F;
Am J Gastroenterol; 2019 Feb; 114(2):258-266. PubMed ID: 30538290
[TBL] [Abstract][Full Text] [Related]
18. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.
Loffredo L; Pastori D; Farcomeni A; Violi F
Gastroenterology; 2017 Aug; 153(2):480-487.e1. PubMed ID: 28479379
[TBL] [Abstract][Full Text] [Related]
19. Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis.
La Mura V; Tripodi A; Tosetti G; Cavallaro F; Chantarangkul V; Colombo M; Primignani M
Liver Int; 2016 Sep; 36(9):1322-30. PubMed ID: 26854258
[TBL] [Abstract][Full Text] [Related]
20. Nontumorous Portal Vein Thrombosis in Liver Cirrhosis: Possible Role of β-Blockers.
Giannitrapani L; Granà W; Licata A; Schiavone C; Montalto G; Soresi M
Med Princ Pract; 2018; 27(5):466-471. PubMed ID: 30107378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
